Microbot Medical Inc.
288 Grove Street, Suite 388
Braintree, MA 02184
| January 23, 2024 |
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. St., N.E.
Washington, D.C. 20549
| Re: | Request for Acceleration of Effectiveness of Registration Statement on Form S-1 (File No. 333-276487) |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Microbot Medical Inc. hereby requests the acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-276487) so that it will become effective on Thursday, January 25, 2024 at 4:00 p.m., Eastern Time, or as soon thereafter as practicable.
| Very truly yours, | ||
| Microbot Medical Inc. | ||
| By: | /s/ Harel Gadot | |
| Name: | Harel Gadot | |
| Title: | CEO, President and Chairman | |
